Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €103.70 EUR
Change Today -0.05 / -0.05%
Volume 10.0K
BOI On Other Exchanges
EN Paris
As of 12:35 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

boiron sa (BOI) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/25/15 - €110.00
52 Week Low
08/4/14 - €56.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BOIRON SA (BOI)

Related News

No related news articles were found.

boiron sa (BOI) Related Businessweek News

No Related Businessweek News Found

boiron sa (BOI) Details

Boiron SA, a pharmaceutical company, together with its subsidiaries, manufactures and sells nonproprietary homeopathic medicines and OTC medication specialties. It offers homeopathic medicines in two family groups, including medicines associated with precise therapeutic indications and dosage in the form of tablets, syrups, creams, and single-dose liquids; and medicines that do not mention a therapeutic indication or dosage in the form of tubes, granular tubes, and cellular doses. The company produces its medicines by using vegetable, animal, and mineral substances. It primarily operates in France, rest of Europe, and North America. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

3,700 Employees
Last Reported Date: 08/29/14
Founded in 1932

boiron sa (BOI) Top Compensated Officers

Chief Pharmacist, Director of Production & Di...
Total Annual Compensation: €496.0K
General Manager and Director
Total Annual Compensation: €896.5K
Compensation as of Fiscal Year 2013.

boiron sa (BOI) Key Developments

Boiron SA Reports Audited Consolidated Group Earnings Results for the Year Ended December 31, 2014

Boiron SA reported audited consolidated group earnings results for the year ended December 31, 2014. For the year, the group reported consolidated sales were €609,748,000 compared to €617,731,000 a year ago. Operating income was €144,177,000 compared to €134,306,000 a year ago. Net Income - Group share was €89,049,000 compared to €82,396,000 a year ago. Cash Flow was €158,518,000 compared to €164,310,000 a year ago.

Boiron SA Presents at Oddo Midcap Forum, Jan-08-2015

Boiron SA Presents at Oddo Midcap Forum, Jan-08-2015 . Venue: Lyon’s Convention Center, Lyon, France.

Boiron SA Reports Group Sales Results for the Third Quarter and Nine Months Ended September 30, 2014

Boiron SA reported group sales results for the third quarter and nine months ended September 30, 2014. Sales revenue in the third quarter 2014 grew by 1.5% compared to 2013 and 3.3% at constant rates. Sales revenue was EUR 172,112,000 against EUR 169,486,000 last year. For the nine months, sales revenue was EUR 433,728,000 against EUR 445,270,000 last year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOI:FP €103.70 EUR -0.05

BOI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BOI.
View Industry Companies

Industry Analysis


Industry Average

Valuation BOI Industry Range
Price/Earnings 20.9x
Price/Sales 2.7x
Price/Book 4.2x
Price/Cash Flow 20.9x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOIRON SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at